Peptide Synthesis Technologies Enabling Faster Therapeutic Development and Scale Up
Peptide synthesis has become a cornerstone technology in modern pharmaceutical and biotechnology development, enabling the rapid production of short and long-chain amino acid sequences for therapeutics, diagnostics, vaccines, and research tools. As drug discovery increasingly focuses on targeted and biologically active molecules, peptides offer a unique middle ground between small molecules and large biologics, combining specificity with relatively straightforward manufacturing. Technically, solid-phase peptide synthesis (SPPS) remains the dominant methodology. This approach anchors the growing peptide chain to a resin support, allowing repetitive cycles of deprotection and coupling to build precise sequences with high efficiency. Advances in automated synthesizers, high-performance reagents, and optimized protecting groups have significantly improved yields while reducing synthesis time and reagent consumption. Liquid-phase synthesis continues to serve specialized applications, ...